Literature DB >> 17192051

Down regulation of adhesion protein E-cadherin in Epstein-Barr virus infected nasopharyngeal carcinomas.

Smriti M Krishna1, Jayashree Kattoor, Prabha Balaram.   

Abstract

Nasopharyngeal carcinoma (NPC) is a unique tumour due to its aetiology, incidence pattern and its consistent association with Epstein-Barr virus (EBV). EBV encodes many viral proteins, which targets crucial cell cycle regulatory proteins. Cadherins are a family of transmembrane glycoproteins, which mediates Ca2+-dependent intercellular adhesion. Epithelial (E)-cadherin is an important member of this family, which is expressed predominantly on the surface of epithelial cells. E-cadherin acts as an invasion/metastasis-suppressor gene, hence knowledge of the molecular mechanism that controls its expression or function is of primary importance in understanding the process of tumor invasion. Loss of E-cadherin function has been shown to potentiate tumor cell invasion and interestingly, a large number of invasive tumors do not involve mutation of E-cadherin, but rather down regulation of expression. Hence in this study, an attempt was made to evaluate the protein level expression pattern of E-cadherin in relation to viral involvement and to correlate it with other clinico-pathological parameters. We observed a significant down regulation of E-cadherin in NPC and its histological subsets, when compared to the controls (p<0.001). Expression of E-cadherin ranged from mild to moderate and none of the NPC showed intense expression. E-cadherin expression showed a significant down-regulation in NPC lesions with EBV infection (r=-0.436, p<0.001). The down regulation of E-cadherin observed in NPC is in line with the previous reports in E-cadherin expression in various cancers. The total lack of E-cadherin expression in neoplastic cells might be due to hypermethylation of E-cadherin promoter or its down regulation by cellular transcription repressor. Our study also shows a significant down regulation of E-cadherin in the presence of EBV, which also might involve the cellular DNA methylation machinery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 17192051     DOI: 10.3233/cbm-2005-1602

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  15 in total

Review 1.  Connections matter--how viruses use cell–cell adhesion components.

Authors:  Mathieu Mateo; Alex Generous; Patrick L Sinn; Roberto Cattaneo
Journal:  J Cell Sci       Date:  2015-02-01       Impact factor: 5.285

2.  Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein.

Authors:  Joanna Laurson; Sadaf Khan; Rachel Chung; Karen Cross; Kenneth Raj
Journal:  Carcinogenesis       Date:  2010-02-01       Impact factor: 4.944

3.  Aberrant gene promoter methylation of E-cadherin, p16 INK4a , p14 ARF , and MGMT in Epstein-Barr virus-associated oral squamous cell carcinomas.

Authors:  Ati Burassakarn; Chamsai Pientong; Nuchsupha Sunthamala; Jureeporn Chuerduangphui; Patravoot Vatanasapt; Natcha Patarapadungkit; Bunkerd Kongyingyoes; Tipaya Ekalaksananan
Journal:  Med Oncol       Date:  2017-06-02       Impact factor: 3.064

4.  Role of DNA methylation in head and neck cancer.

Authors:  Semra Demokan; Nejat Dalay
Journal:  Clin Epigenetics       Date:  2011-07-09       Impact factor: 6.551

5.  Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma.

Authors:  Longmei Cai; Yanfen Ye; Qiang Jiang; Yuxiang Chen; Xiaoming Lyu; Jinbang Li; Shuang Wang; Tengfei Liu; Hongbing Cai; Kaitai Yao; Ji-Liang Li; Xin Li
Journal:  Nat Commun       Date:  2015-07-02       Impact factor: 14.919

Review 6.  Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer.

Authors:  Shyam Singh; Hem Chandra Jha
Journal:  J Oncol       Date:  2017-03-21       Impact factor: 4.375

7.  Transcriptional repression of E-cadherin by human papillomavirus type 16 E6.

Authors:  Zarina J D'Costa; Carol Jolly; Elliot J Androphy; Andrew Mercer; Charles M Matthews; Merilyn H Hibma
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

8.  Expression profiling of 21 biomolecules in locally advanced nasopharyngeal carcinomas of Caucasian patients.

Authors:  Dimitrios Krikelis; Mattheos Bobos; Georgia Karayannopoulou; Liliana Resiga; Sofia Chrysafi; Epaminontas Samantas; Dimitrios Andreopoulos; Vassilios Vassiliou; Elisabeta Ciuleanu; George Fountzilas
Journal:  BMC Clin Pathol       Date:  2013-01-29

9.  The Epstein-Barr virus-encoded microRNA MiR-BART9 promotes tumor metastasis by targeting E-cadherin in nasopharyngeal carcinoma.

Authors:  Chung-Yuan Hsu; Yung-Hsiang Yi; Kai-Ping Chang; Yu-Sun Chang; Shu-Jen Chen; Hua-Chien Chen
Journal:  PLoS Pathog       Date:  2014-02-27       Impact factor: 6.823

10.  Klf4 reduces stemness phenotype, triggers mesenchymal-epithelial transition (MET)-like molecular changes, and prevents tumor progression in nasopharygeal carcinoma.

Authors:  Xiqing Li; Zhunlan Zhao; Xiaoling Zhang; Sheng Yang; Xia Lin; Xinglong Yang; Xiaolin Lin; Junwen Shi; Shengchun Wang; Wentao Zhao; Jing Li; Fei Gao; Mingyue Liu; Ning Ma; Weiren Luo; Kaitai Yao; Yan Sun; Shengjun Xiao; Dong Xiao; Junshuang Jia
Journal:  Oncotarget       Date:  2017-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.